Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Delivery of CSV Normand Jarl to new owner

Skudeneshavn, Norway, 15 February 2023 – Normand Ships AS, a wholly owned subsidiary of Solstad Offshore ASA (Solstad Offshore, OSE: SOFF), has delivered the CSV Normand Jarl to the new owner according to the terms described in a stock exchange announcement made on 12 December 2022. Solstad Offshore will recognize a gain on the sale of approximately MNOK 420 to be reflected in the Q1 2023 accounts. For further information, please contact:Lars Peder Solstad, CEO, tel: + 47 91 31 85 85Kjetil Ramstad, CFO, tel +47 90 75 94 89

BioStock: PHI comments on the new senior positions in the company

Phase Holographic Imaging has appointed its founder and former CEO, Peter Egelberg, as Chairman of the Board, while the company’s former CFO, Patrik Eschricht, has stepped into the CEO position. To better understand the background behind this shift in management, BioStock reached out to both for a Q&A.Read the full interview with Patrik Eschricht and Peter Egelberg at biostock.se: https://www.biostock.se/en/2023/02/phi-comments-on-the-new-senior-positions-in-the-company/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Notice to Annual General Meeting in Atrium Ljungberg AB (publ)

The shareholders of Atrium Ljungberg AB (publ) are hereby invited to the Annual General Meeting to be held on Wednesday 22 March 2023 at 5.00 p.m. at Filmstaden, Marcusplatsen 19 in Sickla, NackaThe Board of Directors has decided that shareholders shall have the right to exercise their voting rights in advance through an absentee ballot pursuant to Chapter 7, section 4 a of the Swedish Companies Act (2005:551) and the Company’s Articles of Association. Consequently, shareholders may choose to exercise their voting rights at the General Meeting by attending by absentee ballot, in person or

2022 Year-end report

Third consecutive year of strong growthWe entered the fourth quarter with a record order and on the back of favourable forecasts, at the same announcing that customers had been forced to postpone production due to the shortage of components in the market. The turbulence in the market notwithstanding, we increase our net sales by 47 percent for the full year. We move into 2023 with an order book of MSEK 230 and additional orders for the existing product portfolio of MSEK 120 for delivery in 2024-25. The volumes we expect at the end of this year provide opportunities to reach profitability

Swedbank and Folksam sign declaration of intent for deepened commercial collaboration

Swedbank and Folksam have a long-established commercial collaboration in areas such as asset management and non-life insurance to create customer benefit. The parties have now signed a declaration of intent to jointly explore opportunities to extend the collaboration to create attractive customer offers within their respective operations, including lending and insurance products.“Together we can create a more comprehensive and attractive offer for our customers. Folksam and Swedbank already have a commercial collaboration that is beneficial to both parties. I foresee that this declaration

BIOHIT GROUP FINANCIAL STATEMENT RELEASE 2022

Biohit Oyj Financial Statement Release 15 February 2023 at 9:30 am local time (EET) SUMMARY January-December 2022       · Revenue EUR 11.0 million (EUR 9.4 million) · Revenue grew by 17.0% compared to 2021 · Operative EBITDA EUR +1.8 million (EUR 0,5 million) · Cash at the end of the period EUR 2.1 million (EUR 1.1 million) · Fair value of Genetic Analysis AS investment EUR 0.3 million (EUR 0.9 million 31 December 2021) · Revenue from international operations 97.9% (97.5%) of total revenue · Equity ratio 68.3% (76.3%) July-December 2022 · Revenue EUR 4.8

BoMill Year-End Report, January – December 2022

BoMill AB (”BoMill” or the “Company”) hereby publishes the Year-End Report for the period January 1 – December 31, 2022. The Year-End Report is available as an attached file to this release and on BoMill’s website. Below is a summary of the report.CEO Andreas Jeppsson comments: “During the fourth quarter of 2022, the team has focused on the launch of BoMill InSight™. We are ready for launch, and I am convinced 2023 will be an exciting year for BoMill.” Net sales and income for the fourth quarter (October – December 2022) · Net sales amounted to KSEK 20 (KSEK 578) · Net income

MEDIVIR AB – YEAR-END REPORT JANUARY – DECEMBER 2022

Continued strong recruitment in the dose escalation part of the fostrox study.   October – December Financial summary for the quarter · Net turnover amounted to SEK 2.3 (13.9) million. · The loss before interest, tax, depreciation and amortization (EBITDA) amounted to SEK -17.9 (-23.5) million. Basic and diluted earnings per share amounted to SEK -0.32 (-0.44) and SEK -0.32 (-0.44) respectively. · Cash flow from operating activities amounted to SEK -24.7 (-5.4) million. · Cash and cash equivalents at the end of the period amounted to SEK 117.4 (221.2) million.

Waupaca Foundry roll out Ironhand to three additional sites

Waupaca Foundry have successfully used Ironhand to reduce injuries at their site in Marinette, WI, USA. With proven results Waupaca have decided to proceed a roll out at additional three sites, totaling a number of 60 Ironhand systems to be actively in use during the second quarter. The additional 30 Ironhand systems to be used in the phase 2 roll out are sold at an order value of MSEK 1,8 MSEKWaupaca Foundry, Bioservo, and Rhino Tool House have successfully concluded a seven-month partnership project where 30 Ironhand systems have been used, primarily for grinding operations, at their site

ORGANOCLICK AB (PUBL) PUBLISH YEAR END REPORT FOR 2022

During the fourth quarter, a new OrganoClick started to emerge. A more cost-effective company with a clear focus on green chemistry and profitable growth. The changes we are implementing now, will gradually turn us into a purely green chemical company. The unfavourable economic environment for consumer products notwithstanding, the Group’s overall sales increased by 20.5 (-1.4) percent during the fourth quarter, to MSEK 21.6 (18.0), through strong growth of binder sales. Restructuring costs related to the discontinued production of biocomposites resulted in a deterioration of EBIT. On the

HC Andersen Capital Events 15/02: Meet the top management in ExpreS2ion Biotechnologies

HC Andersen Capital is hosting a digital event where you can meet and ask questions directly to the top management. It is free for all to attend.ExpreS2ion Biotechnologies - Presentation of year-end report 2022On the 9th of February, ExpreS2ion Biotechnologies released its Q4 2022 and full-year 2022 results. In Q4 2022, the company's operating income fell 64% to SEK 1.59m, and the loss from the period amounted to SEK -48.5m in the quarter (SEK -14.3m in Q4 2021).   The operating income is as expected, as the focus is shifted from its legacy CRO business to developing pipeline

Invitation to presentation of Thunderful Group´s year-end report 2022

Thunderful Group invites to a webcast February 22, 2023, 10.00 CET.The year-end report for 2022 is presented and thereafter there is an opportunity to ask questions. Questions can be posed in writing via the webcast. A recorded version of the presentation will also be available on Thunderful Group's website. The presentation will be held in English. The year-end report is published at 07.30 CET February 22, 2023. The presentation will be moderated by Simon Jönsson, analyst at ABG Sundal Collier. Present:Anders Maiqvist, Acting CEOLennart Sparud, CFO To access the audiocast,

Axactor ASA: Invitation to presentation of Q4 2022 results

Axactor ASA will publish its fourth quarter 2022 results on Friday 17 February2023. 07:00 am CET: The report and presentation will be made available onaxactor.com and newsweb.oslobors.no. 10:00 am CET: The results will be presented in a global investor webcast witha live Q&A session. A recording of the webcast will be made available afterthe live stream is concluded on axactor.com. Webcast participation will be possible via the following: Streaming- https://app.webinar.net/meZqdGjL1Ob Phone- Dial-in pin: 478639- Norway: +47 81 50 33 08- Sweden: +46 10 884 80

Nokian Tyres: Disclosure under chapter 9, section 10 of the securities market act

Nokian Tyres plc Stock Exchange Release February 15, 2023 at 9:15 a.m. Nokian Tyres has received an announcement from Norges Bank (The Central Bank of Norway) on February 14, 2023, in accordance with the Finnish Securities Market Act Chapter 9, Section 5. According to the announcement, Norges Bank’s (The Central Bank of Norway) direct holding in Nokian Tyres shares and voting rights fell below the level of 5% of the share capital in Nokian Tyres plc, as a result of share transactions concluded on February 13, 2023. The direct shareholding of Norges Bank (The Central Bank of Norway) in

Invitation to presentation of Embellence Group’s interim report for the fourth quarter 2022

Embellence Group publishes the quarterly report for the fourth quarter 2022 on February 21 at 08:00 CET. In connection with the announcement, Embellence Group invites to a conference call on the same day, held at 10:00 CET.The presentation will be held in English by Olle Svensk (CEO) and Karin Lidén (CFO). If you wish to participate via webcast please use the link below. Via the webcast you are able to ask written questions.Embellence Group Q4 Report 2022 (financialhearings.com)  If you wish to participate via teleconference

Up to 60% more food out of fish by using bones, scales and other hard tissues in a sustainable and tasty way – Finnish food tech SuperGround is the first in the world to make this possible

SuperGround’s one-of-a-kind food production solution enables making significantly more fish food products by utilizing the whole fish while also reducing raw material waste, making the fish industry more efficient and sustainable by helping to reduce overfishing. Pictures of fish products made with the technology can be found here .KOTKA, Finland (February 15th, 2023). Last year, Finnish food tech company SuperGround  launched a unique and innovative food production technology. It enabled

Year-End report January – December 2022

Fourth quarter in brief · Net sales amounted to 20,6 million SEK (18,4), which means a sales growth of 12 percent. ·Operating profit amounted to 2,1 million SEK (5,2), corresponding to an operating margin of 10 percent (28). ·Net profit for the period amounted to 0,5 million SEK (3,1). ·Earnings per share amounted to 0.01 SEK (0.08). Full year January - December in brief · Net sales for the full year 2022 amounted to 68,3 million SEK (58,4), which means a sales growth of 17 percent. ·Operating profit amounted to 7,2 million SEK (10,0),

Assemblin installs in new multi-technical healthcare and research project

Assemblin secures new healthcare sector installation assignment in Linköping. Assemblin will install electrical, heating, sanitation, ventilation and sprinkler systems in a new building under construction in the Garnisonen district. The order is valued at about SEK 70 million in total.Region Östergötland will conduct outpatient care and research in the new six-floor building. The goal is for “Building C” to meet the requirements for BREEAM’s environmental certification Excellent. Assemblin’s client is the construction company Åhlin & Ekeroth AB, which is constructing the new building in

Year-end Report January-December 2022

The strong growth in the core business during the fourth quarter continues in the beginning of 2023 October-December 2022 · Net sales totaled SEK 25,741 (42,060) thousand. Organic growth adjusted for license revenue from Selecta Biosciences in 2021 is 38% and when also adjusted for currency effect 21%. Net sales including license revenue from Selecta Biosciences decreased by -39% and adjusted for currency effect -48%. · Gross profit totaled SEK 23,031 (39,024) thousand. · Operating profit before depreciation and amortization (EBITDA) totaled SEK -5,915 (23,361) thousand.

Best year ever for First Camp Group

First Camp Group is announcing today a record-high result for 2022. Total reported revenues more than doubled in 2022, from 473 to SEK 1,004 million, and reported EBITDA increased from 115 to SEK 201 million. Also organic growth was very strong at +18%.”The combination of continued acquisitions, investments in our product and commercial activites, strong market demand and efficient operations, have led to this record result. In addition to these strong financial results, we also reached an all-time-high in guest satisfaction. A big thank you to all talented colleagues in First Camp Group

­­Finnair Group Financial Statements Release 1 January – 31 December 2022

Finnair Plc            Financial Statement Release            15 February 2023 at 9.00 a.m. EET Comparable EBIT positive for the second consecutive quarter; work to restore profitability continues. October – December 2022 · Earnings per share were 0.03 euros (-0.06)*. · Revenue increased by 66.2% to 687.3 million euros (413.5). · Comparable operating result was 17.9 million euros (-65.2). Operating result was 38.0 million euros (-60.2). · Exceptionally high fuel price had an adverse cost impact of c. 94 million euros** year-on-year. · Cash funds were 1,524.4 million

Invitation to presentation of Catena Media’s Q4 results 2022

Catena Media’s year-end report for the fourth quarter that ended 31 December 2022 will be published in English on Wednesday 22 February at 07:00 CET. Following the report’s release, a combined presentation audiocast and telephone conference with the opportunity to ask questions will be held at 09:00 CET on the same day, with CEO Michael Daly and Group CFO Peter Messner presenting the report. WebcastVia the webcast you are able to ask written questions. If you wish to participate via webcast, please use the following link: https://ir.financialhearings.com/catena-media-q4-2022

There are no items matching the current filter
There are no more items matching the current filter
Back to top